{
  "last_updated": "2026-02-24T19:19:21",
  "portfolio": {
    "total_invested_eur": 625.27,
    "total_value_eur": 625.27,
    "unrealized_pnl_eur": -0.0,
    "unrealized_pnl_pct": -0.0,
    "positions": [
      {
        "ticker": "AVTR_US_EQ",
        "quantity": 68.56,
        "avg_buy_price": 9.12,
        "current_price": 9.12,
        "invested_eur": 625.27,
        "current_value_eur": 625.27,
        "pnl_eur": 0.0,
        "pnl_pct": 0.0,
        "days_held": 0
      }
    ]
  },
  "runs": [
    {
      "date": "2026-02-24",
      "run_number": 1,
      "insider_count": 18,
      "confidence": 62,
      "market_summary": "Broad insider buying across healthcare and industrials with two strong cluster buys (TLSI, TLPH) and several large dip-buy signals (AVTR, LPX, PODD). Portfolio positions are all freshly opened today with minimal P&L movement — no sell triggers hit. Deploying into 4 new names not already in the portf",
      "total_spent_eur": 2500.0,
      "picks": [
        {
          "ticker": "TLSI",
          "allocation_pct": 30.0,
          "reasoning": "Strongest cluster buy in the cohort: 4 insiders including CEO Szela spent $1.77M combined, with 100% stake increase. Earnings on March 26 is a near-term catalyst with strong revenue growth trajectory.",
          "executed": true,
          "amount_eur": 750.0,
          "quantity": 0.0
        },
        {
          "ticker": "LPX",
          "allocation_pct": 30.0,
          "reasoning": "Director doubled their stake with a $1.71M purchase — largest single dollar commitment in the cohort. Stock down ~15% over 6 months near 52w low, classic dip-buy signal. Low D/E of 21.9 and profitable",
          "executed": true,
          "amount_eur": 750.0,
          "quantity": 0.0
        },
        {
          "ticker": "ELF",
          "allocation_pct": 20.0,
          "reasoning": "Director increased stake by 86% ($465K) after a 17% 6-month decline from highs near $151. Positive MACD (+1.57) and 1-month return of +6.6% suggest trend reversal is underway. Strong brand in growing ",
          "executed": true,
          "amount_eur": 500.0,
          "quantity": 0.0
        },
        {
          "ticker": "TLPH",
          "allocation_pct": 20.0,
          "reasoning": "Cluster buy with 4 insiders including CEO and CMO spending $179K in a $43M market cap company — that's meaningful relative to company size. CEO, CMO, and Chief Engineering Officer all buying suggests ",
          "executed": true,
          "amount_eur": 500.0,
          "quantity": 0.0
        }
      ]
    },
    {
      "date": "2026-02-24",
      "run_number": 2,
      "insider_count": 18,
      "confidence": 74,
      "market_summary": "Strong insider buying week across healthcare and industrials with two high-conviction cluster buys (TLSI and CNDT) featuring C-suite participation. TLSI stands out with 4 insiders including CEO buying $1.77M ahead of March earnings. AVTR offers the deepest value play with a 572% stake increase into ",
      "total_spent_eur": 2500.0,
      "picks": [
        {
          "ticker": "TLSI",
          "allocation_pct": 30.0,
          "reasoning": "Highest conviction signal: 4 insiders including CEO buying $1.77M in a cluster buy, with one insider doubling their stake (100% ΔOwn). Earnings on March 26 is a near-term catalyst — insiders buying ~1",
          "executed": true,
          "amount_eur": 750.0,
          "quantity": 0.0
        },
        {
          "ticker": "AVTR",
          "allocation_pct": 25.0,
          "reasoning": "Director increased stake by 572% ($458K) — an extraordinary proportional increase into a stock down 48% over 1 year and 23% in the last month alone. RSI at 31.9 is near oversold. This is a classic dee",
          "executed": true,
          "amount_eur": 625.0,
          "quantity": 0.0
        },
        {
          "ticker": "WY",
          "allocation_pct": 20.0,
          "reasoning": "Cluster buy from 2 directors totalling $615K, with one increasing stake by 492%. Stock down 14% on 1Y with RSI at 36.5 — buying into weakness. Ex-dividend date March 10 provides near-term income catal",
          "executed": true,
          "amount_eur": 500.0,
          "quantity": 0.0
        },
        {
          "ticker": "CNDT",
          "allocation_pct": 15.0,
          "reasoning": "CEO plus 2 other insiders buying $656K in a cluster buy after a 58% 1Y decline and 44% 6M decline — this is deep distress-level buying from the people running the company. CEO increasing stake by 57% ",
          "executed": true,
          "amount_eur": 375.0,
          "quantity": 0.0
        },
        {
          "ticker": "PODD",
          "allocation_pct": 10.0,
          "reasoning": "CEO purchased $1.03M in shares, increasing ownership by 45%, after stock fell 25% over 6 months. This is the highest absolute dollar C-suite buy among candidates. MACD histogram turning positive sugge",
          "executed": true,
          "amount_eur": 250.0,
          "quantity": 0.0
        }
      ]
    }
  ],
  "portfolio_history": [
    {
      "date": "2026-02-24",
      "total_invested_eur": 625.27,
      "total_value_eur": 625.27,
      "unrealized_pnl_eur": -0.0
    }
  ]
}